Bio Works Technologies Ab Stock Return On Equity
| BIOWKS Stock | SEK 1.57 0.01 0.63% |
Bio Works Technologies AB fundamentals help investors to digest information that contributes to Bio Works' financial success or failures. It also enables traders to predict the movement of Bio Stock. The fundamental analysis module provides a way to measure Bio Works' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bio Works stock.
Bio |
Bio Works Technologies AB Company Return On Equity Analysis
Bio Works' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Bio Works Return On Equity | -0.66 |
Most of Bio Works' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bio Works Technologies AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Bio Works Technologies AB has a Return On Equity of -0.6619. This is 97.24% lower than that of the Healthcare sector and 98.18% lower than that of the Biotechnology industry. The return on equity for all Sweden stocks is 113.52% higher than that of the company.
Bio Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bio Works' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bio Works could also be used in its relative valuation, which is a method of valuing Bio Works by comparing valuation metrics of similar companies.Bio Works is currently under evaluation in return on equity category among its peers.
Bio Fundamentals
| Return On Equity | -0.66 | |||
| Return On Asset | -0.35 | |||
| Profit Margin | (1.31) % | |||
| Operating Margin | (1.27) % | |||
| Current Valuation | 635.01 M | |||
| Shares Outstanding | 34.87 M | |||
| Shares Owned By Insiders | 54.85 % | |||
| Shares Owned By Institutions | 5.59 % | |||
| Price To Book | 8.03 X | |||
| Price To Sales | 19.71 X | |||
| Revenue | 21.91 M | |||
| Gross Profit | 53.01 M | |||
| EBITDA | (8.6 M) | |||
| Net Income | (12.94 M) | |||
| Cash And Equivalents | 46.35 M | |||
| Cash Per Share | 2.40 X | |||
| Current Ratio | 9.14 X | |||
| Book Value Per Share | 2.55 X | |||
| Cash Flow From Operations | (13.37 M) | |||
| Earnings Per Share | (0.41) X | |||
| Target Price | 27.0 | |||
| Number Of Employees | 36 | |||
| Beta | 0.99 | |||
| Market Capitalization | 718.4 M | |||
| Total Asset | 120.86 M | |||
| Net Asset | 120.86 M |
About Bio Works Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bio Works Technologies AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio Works using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Works Technologies AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Bio Stock
Bio Works financial ratios help investors to determine whether Bio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bio with respect to the benefits of owning Bio Works security.